These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1535206)

  • 21. Potency versus onset of neuromuscular blocking agents.
    Gyermek L
    Anesthesiology; 1993 Apr; 78(4):795-7. PubMed ID: 8466083
    [No Abstract]   [Full Text] [Related]  

  • 22. New neuromuscular blocking drugs.
    Hunter JM
    N Engl J Med; 1995 Jun; 332(25):1691-9. PubMed ID: 7760871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromuscular block.
    Feldman S
    Anaesth Intensive Care; 1997 Jun; 25(3):313-4. PubMed ID: 9209625
    [No Abstract]   [Full Text] [Related]  

  • 24. The contributions of A. W. Hofmann.
    Alston TA
    Anesth Analg; 2003 Feb; 96(2):622-5, table of contents. PubMed ID: 12538223
    [No Abstract]   [Full Text] [Related]  

  • 25. Muscle relaxant drugs.
    Thompson MA
    Br J Hosp Med; 1980 Feb; 23(2):153-4, 163-4, 167-8 passim. PubMed ID: 6102875
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuromuscular blockers in patients with burns.
    Lancet; 1988 Oct; 2(8618):1003-4. PubMed ID: 2902437
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical assessment of neuromuscular transmission.
    Viby-Mogensen J
    Br J Anaesth; 1982 Feb; 54(2):209-23. PubMed ID: 6277354
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro response of neuromuscular blockers after chronic carbamazepine treatment in rats.
    Nguyen A; Ramzan I
    Pharmazie; 2000 Dec; 55(12):957. PubMed ID: 11189879
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuromuscular blocking agents in paediatric anaesthesia.
    Fisher DM
    Br J Anaesth; 1999 Jul; 83(1):58-64. PubMed ID: 10616334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuromuscular block.
    Bowman WC
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S277-86. PubMed ID: 16402115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacology of neuromuscular blocking agents.
    Fisher DM
    Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S4-9. PubMed ID: 10437710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect sites of neuromuscular blocking agents and the monitoring of clinical muscle relaxation.
    Meistelman C
    Adv Exp Med Biol; 2003; 523():227-38. PubMed ID: 15088854
    [No Abstract]   [Full Text] [Related]  

  • 34. The antagonism of nondepolarizing neuromuscular blockade.
    Jenkins TE
    AANA J; 1980 Oct; 48(5):452-60. PubMed ID: 6449820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance of myorelaxants in anesthesia.
    Flood P
    Curr Opin Pharmacol; 2005 Jun; 5(3):322-7. PubMed ID: 15907920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzylisochinoline muscle relaxants in clinical practice.
    Werba A; Schultz AM; Hetz H; Wiesinger KH
    Acta Anaesthesiol Scand Suppl; 1997; 111():109-10. PubMed ID: 9420976
    [No Abstract]   [Full Text] [Related]  

  • 37. [Recent clinical advance of rocuronium pharmacokinetics and a new neuromuscular reversal agent, sugammadex].
    Iwasaki H
    Hokkaido Igaku Zasshi; 2012 Aug; 87(4-5):133-5. PubMed ID: 23236656
    [No Abstract]   [Full Text] [Related]  

  • 38. Rocuronium bromide and organ function.
    Bevan DR
    Eur J Anaesthesiol Suppl; 1994; 9():87-91. PubMed ID: 7925215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A kinetic-dynamic model to explain the relationship between high potency and slow onset time for neuromuscular blocking drugs.
    Donati F; Meistelman C
    J Pharmacokinet Biopharm; 1991 Oct; 19(5):537-52. PubMed ID: 1783991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.